FAQs
ATON is committed to serving you. The following is a list of frequently asked questions about TIMOPTIC® in OCUDOSE® that may not have been specifically addressed on our site:
How long does it take for TIMOPTIC® in OCUDOSE® to reduce IOP?
Will I always have to take TIMOPTIC® in OCUDOSE® twice a day?
Can TIMOPTIC® in OCUDOSE® be combined with other glaucoma medications?
Can I use TIMOPTIC® in OCUDOSE® if I am wearing contact lenses?
After the OCUDOSE® unit is opened, how long do I have to administer the eye drop?
Will my insurance cover TIMOPTIC® in OCUDOSE® to reduce IOP?
What should I do if I experience a side effect while using TIMOPTIC® in OCUDOSE®?
What if I still have a question that wasn’t covered here?
How long does it take for TIMOPTIC® in OCUDOSE® to reduce IOP?
Following administration of a single dose of TIMOPTIC®, the reduction of IOP can be detected within one-half hour.1
Will I always have to take TIMOPTIC® in OCUDOSE® twice a day?
Yes, when first starting on treatment, TIMOPTIC® in OCUDOSE® should be taken twice a day, because some patients require more time for their IOP to stabilize. After four weeks, your ophthalmologist should evaluate your IOP.1
If IOP is maintained at satisfactory levels, dosage administration can be changed to one drop per day in the affected eye(s).
Can TIMOPTIC® in OCUDOSE® be combined with other glaucoma medications?
Yes, but you should discuss this with your eye care professional prior to combining TIMOPTIC® in OCUDOSE® with other glaucoma medications.
Can I use TIMOPTIC® in OCUDOSE® if I am wearing contact lenses?
Yes, but you should discuss this with your eye care professional prior to using TIMOPTIC® in OCUDOSE® while wearing contact lenses.
After the OCUDOSE® unit is opened, how long do I have to administer the eye drop?
Administration of the solution should occur immediately after opening. Since the solution is sterile and does not contain a preservative, sterility cannot be guaranteed after the unit it opened, and remaining contents should be discarded.1
Will my insurance cover TIMOPTIC® in OCUDOSE® to reduce IOP?
Yes, TIMOPTIC® in OCUDOSE® is covered by most insurance plans. A knowledgeable representative can address any question you may have about TIMOPTIC® in OCUDOSE® or your insurance plan. Contact the Valeant Patient Assistance directly by calling (866) 268-7325, Monday – Friday 9am-5pm (except holidays) for more information on Valeant Patient Assistance.
You can save an extra $20 off your prescription co-pay through this rebate offer.
What should I do if I experience a side effect while using TIMOPTIC® in OCUDOSE®?
In the event that you experience any side effects while using TIMOPTIC® in OCUDOSE®, contact one of our medical specialists at Valeant Pharmaceuticals Medical Affairs at (877) 361-2719.
What if I still have a question that wasn’t covered here?
If your question wasn’t answered here, e-mail Customer Service or contact us directly at Valeant Pharmaceuticals at (800) 321-4576.
INDICATIONS AND USAGE
Preservative-free TIMOPTIC® in OCUDOSE® is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Preservative-free TIMOPTIC® in OCUDOSE® may be used when a patient is sensitive to the preservative in Timoptic (timolol maleate ophthalmic solution), benzalkonium chloride, or when use of a preservative-free topical medication is advisable.
IMPORTANT SAFETY INFORMATION
Timoptic is contraindicated in patients with: bronchial asthma; a history of bronchial asthma; severe chronic obstructive pulmonary disease; sinus bradycardia; second or third degree atrioventricular block; overt cardiac failure; cardiogenic shock; hypersensitivity to any component of this product.
This drug is absorbed systemically. The same adverse reactions found with systemic administration of beta-adrenergic blocking agents may occur with topical administration. Severe respiratory or cardiac reactions, including death, have been reported following systemic or ophthalmic administration of timolol maleate. Timoptic should be used with caution in patients with cerebrovascular insufficiency.
The most frequently reported adverse experiences have been burning and stinging upon instillation.
You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
Reference: 1. Timoptic (timolol maleate ophthalmic solution) in Ocudose (dispenser) [prescribing information]. Lawrenceville, NJ: Aton Pharma, Inc; 2009.
